Spectrum Pharmaceuticals Inc. [NASDAQ: SPPI] price surged by 0.78 percent to reach at $0.02. The company report on August 10, 2021 that SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. – SPPI.
Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 7980.
The investigation concerns whether Spectrum and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
A sum of 11043833 shares traded at recent session while its average daily volume was at 2.72M shares. Spectrum Pharmaceuticals Inc. shares reached a high of $2.72 and dropped to a low of $2.43 until finishing in the latest session at $2.57.
Guru’s Opinion on Spectrum Pharmaceuticals Inc. [SPPI]:
JMP Securities have made an estimate for Spectrum Pharmaceuticals Inc. shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on September 17, 2020. The new note on the price target was released on December 26, 2019, representing the official price target for Spectrum Pharmaceuticals Inc. stock. Previously, the target price had yet another drop from $17 to $4, while Cantor Fitzgerald kept a Neutral rating on SPPI stock.
The Average True Range (ATR) for Spectrum Pharmaceuticals Inc. is set at 0.22 The Price to Book ratio for the last quarter was 3.06, with the Price to Cash per share for the same quarter was set at 0.79.
SPPI Stock Performance Analysis:
Spectrum Pharmaceuticals Inc. [SPPI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -20.92. With this latest performance, SPPI shares dropped by -27.20% in over the last four-week period, additionally sinking by -34.94% over the last 6 months – not to mention a drop of -33.16% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SPPI stock in for the last two-week period is set at 25.54, with the RSI for the last a single of trading hit 21.46, and the three-weeks RSI is set at 29.72 for Spectrum Pharmaceuticals Inc. [SPPI]. The present Moving Average for the last 50 days of trading for this stock 3.66, while it was recorded at 2.94 for the last single week of trading, and 3.65 for the last 200 days.
Insight into Spectrum Pharmaceuticals Inc. Fundamentals:
Spectrum Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.60 and a Current Ratio set at 3.60.
Spectrum Pharmaceuticals Inc. [SPPI] Insider Position Details
There are presently around $260 million, or 64.40% of SPPI stock, in the hands of institutional investors. The top three institutional holders of SPPI stocks are: BLACKROCK INC. with ownership of 28,173,428, which is approximately 1.267% of the company’s market cap and around 1.50% of the total institutional ownership; STATE STREET CORP, holding 13,126,592 shares of the stock with an approximate value of $33.73 million in SPPI stocks shares; and VANGUARD GROUP INC, currently with $32.45 million in SPPI stock with ownership of nearly 4.362% of the company’s market capitalization.
69 institutional holders increased their position in Spectrum Pharmaceuticals Inc. [NASDAQ:SPPI] by around 9,735,309 shares. Additionally, 68 investors decreased positions by around 8,654,591 shares, while 31 investors held positions by with 82,936,261 shares. The mentioned changes placed institutional holdings at 101,326,161 shares, according to the latest SEC report filing. SPPI stock had 14 new institutional investments in for a total of 505,254 shares, while 23 institutional investors sold positions of 4,207,978 shares during the same period.